Keyword(s):
All | Title:
All | Types of Notice(s):
All | Department(s):
JOINT INFORMATION CENTER - COVID-19 | Division(s):
All | Notice Topic(s):
All | For Audience(s):
All | View Important Deadlines: All | From Date: All | From To: All
Three COVID-19-related Fatalities Reported; COVID-19 Test Results: 46 New Cases, 12 Hospitalized; 48 Cases with Variants of Concern Identified;
FDA Restricts Use of Sotrovimab in Certain States and Territories
Joint Information Center – JIC Release No. 1008 April 1, 2022, 6 p.m. (ChST)
Two COVID-19-related Fatalities Reported; Standing Order Issued for Second Booster Shot for 50 and Older; COVID-19 Test Results: 45 New Cases, 15 Hospitalized; Mangilao mAb Treatment Center Closed Monday; Changes Made to COVID-19 Vaccination and Testing Schedule
Joint Information Center – JIC Release No. 1007 March 31, 2022, 7:30 p.m. (ChST)
343rd COVID-19-related Fatality Reported; COVID-19 Test Results: 59 New Cases, 17 Hospitalized;
Changes Made to COVID-19 Vaccination and Testing Schedule
Joint Information Center – JIC Release No. 1005 March 29, 2022, 6 p.m. (ChST)
Two COVID-19-related Fatalities Reported; Cumulative COVID-19 Test Results: 42 New Cases, 13 Hospitalized;
Changes Made to COVID-19 Vaccination and Testing Schedule
Joint Information Center – JIC Release No. 1004 March 28, 2022, 4:55 p.m. (ChST)